Thursday, 11 February 2021 04:25

New studies show these two common drugs work against Covid-19

Rate this item
(0 votes)

A commonly used asthma treatment appears to reduce the need for hospitalizations and recovery time for Covid-19 patients if given within seven days of symptoms appearing, researchers at the University of Oxford have found. The 28-day study of 146 patients found the inhaled steroid, budesonide, reduced the risk of urgent care, emergency room visits or hospitalization by 90% when compared with usual care. Patients treated at home with budesonide also had a quicker resolution of fever and fewer persistent symptoms. In a report posted on Monday on medRxiv ahead of peer review, the researchers said they undertook the trial because they noticed that patients with chronic respiratory diseases like asthma, who are often prescribed inhaled steroids such as budesonide, were not needing to be hospitalized for Covid-19 as often as expected. "I am heartened that a relatively safe, widely available and well studied medicine ... could have an impact on the pressures we are experiencing during the pandemic," said study leader Mona Bafadhel.

Experimental drug may speed viral clearance

An experimental antiviral drug significantly sped up the time it took to "clear" the virus in Covid-19 patients who did not need to be hospitalized, Toronto researchers have found. In a small trial, patients who received a single injection of peginterferon-lambda were more than four times as likely to test negative for the virus within seven days as patients who received a placebo. "The more rapid viral load decline and higher clearance rate were most pronounced in those with high viral loads" the authors reported on Friday in The Lancet Respiratory Medicine. "The magnitude of the viral load decline compared with that of placebo was much greater ... than has been reported with monoclonal antibody therapies," they added. "This treatment has large therapeutic potential," study leader Jordan Feld of Toronto Center for Liver Disease said in a statement. Respiratory symptoms also appeared to resolve faster with peginterferon-lambda therapy, but the trial was too small to demonstrate a statistically significant difference. Feld's team is planning a much larger trial, and studies are already underway testing the treatment in hospitalized patients.

 

Reuters

November 14, 2024

NNPC signs 10-year gas sale deal with Dangote Refinery

Nigeria's state oil firm, NNPC Ltd said on Wednesday one of its subsidiaries has agreed…
November 12, 2024

Ex-Gov Aregbesola warns of imminent revolution in Nigeria amid rising misery, hunger, insecurity

Former Osun State Governor Rauf Aregbesola has issued a stark warning about the worsening socio-economic…
November 13, 2024

Why being wrong is good for you - The Economist

“Mistakes are the portals of discovery,” wrote James Joyce in “Ulysses”. In 1888 Lee Kum…
November 09, 2024

Sick man brought to bank on hospital bed to confirm his identity

A severely sick Chinese man was pushed to a local bank branch on a hospital…
November 12, 2024

US court issues fresh arrest warrant for Air Peace CEO Allen Onyema

A United States court has reissued an order for the arrest of Allen Onyema, the…
November 14, 2024

What to know after Day 994 of Russia-Ukraine war

RUSSIAN PERSPECTIVE Ukraine could have nuclear weapon in months – report Ukraine could feasibly raid…
November 11, 2024

Hackers are targeting people who type these six words into their computer, smartphones

Computer users Googling whether Bengal cats are legal to own after finding themselves victims of…
October 27, 2024

Nigeria awarded 3-0 win over Libya after airport fiasco

Nigeria have been awarded a 3-0 victory over Libya, and three vital points, from their…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Prof Wale Are Olaitan: Editorial Consultant; Femi Kawonise: Head, Production & Administration; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2024 NewsScroll. All rights reserved.